Shalby Limited
NSE: SHALBY BSE: SHALBY
Prev Close
247.13
Open Price
249.34
Volume
418,363
Today Low / High
246.91 / 254.68
52 WK Low / High
177.25 / 282.5
Range
237 - 262
Prev Close
247.2
Open Price
242.1
Volume
29,102
Today Low / High
242.1 / 254.6
52 WK Low / High
177.2 / 282.3
Range
236 - 261
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 249.35 (target range: 237 - 262), reflecting a change of 2.22 (0.89831%). On the BSE, it is listed at 248.35 (target range: 236 - 261), showing a change of 1.15 (0.46521%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Shalby Limited Graph
Shalby Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Shalby Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 249.35, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
Scenario | Price | Target | Range |
---|---|---|---|
Bullish Scenario | 248.35 | 250.83 | 225.75 - 275.92 |
253.32 | 202.65 - 303.98 | ||
255.80 | 179.06 - 332.54 | ||
Bearish Scenario | 248.35 | 245.87 | 221.28 - 270.45 |
243.38 | 194.71 - 292.06 | ||
240.90 | 168.63 - 313.17 |
Overview of Shalby Limited
ISIN
INE597J01018
Industry
Medical - Care Facilities
Vol.Avg
759,843
Market Cap
26,746,965,359
Last Dividend
1.2
Official Website
IPO Date
2017-12-15
DCF Diff
321.16
DCF
-74
Financial Ratios Every Investor Needs
Stock Dividend of SHALBY
Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
---|---|---|---|---|---|---|
2024-09-19 | September 19, 24 | 1.2 | 1.2 | 2024-09-19 | 2024-10-26 | |
2023-08-08 | August 08, 23 | 1.2 | 1.2 | 2023-08-08 | 2023-09-13 | |
2022-09-19 | September 19, 22 | 1 | 1 | 2022-09-20 | 2022-10-26 | |
2021-09-17 | September 17, 21 | 1 | 1 | 2021-09-20 | 2021-10-27 | |
2020-09-04 | September 04, 20 | 0.5 | 0.5 | 2020-09-07 | 2020-10-14 |
Annual Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 1,086.96 Cr | 885.31 Cr | 201.64 Cr | 0.1855 | 0.00 Cr | 0.00 Cr | 66.85 Cr | 6.22 Cr | 0.58 | 160.20 Cr | 0.0057 |
2024-03-31 | 933.75 Cr | 683.25 Cr | 250.50 Cr | 0.2683 | 0.00 Cr | 4.23 Cr | 223.94 Cr | 84.08 Cr | 7.83 | 198.05 Cr | 0.0900 |
2023-03-31 | 804.92 Cr | 435.11 Cr | 369.81 Cr | 0.4594 | 0.00 Cr | 5.09 Cr | 92.69 Cr | 67.70 Cr | 6.30 | 160.70 Cr | 0.0841 |
2022-03-31 | 698.95 Cr | 394.32 Cr | 304.63 Cr | 0.4358 | 0.00 Cr | 6.81 Cr | 78.76 Cr | 54.13 Cr | 5.01 | 129.55 Cr | 0.0774 |
2021-03-31 | 430.90 Cr | 249.62 Cr | 181.27 Cr | 0.4207 | 0.00 Cr | 1.96 Cr | 51.82 Cr | 42.40 Cr | 3.93 | 96.24 Cr | 0.0984 |
Annual Financials Balance Sheet
Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 34.86 Cr | 1,703.65 Cr | 708.33 Cr | 992.1880 Cr | 475.93 Cr | 441.07 Cr | 319.21 Cr | 896.37 Cr | 0.00 Cr | 0.00 Cr | 22.42 Cr | 455.3240 Cr |
2024-03-31 | 27.18 Cr | 1,607.53 Cr | 599.75 Cr | 1,000.3740 Cr | 377.87 Cr | 350.69 Cr | 235.20 Cr | 906.54 Cr | -0.71 Cr | 0.00 Cr | 2.71 Cr | 323.2640 Cr |
2023-03-31 | 12.24 Cr | 1,281.36 Cr | 353.75 Cr | 927.6860 Cr | 180.51 Cr | 168.26 Cr | 185.40 Cr | 674.19 Cr | 13.90 Cr | 11.39 Cr | 0.33 Cr | 194.3840 Cr |
2022-03-31 | 55.55 Cr | 1,193.54 Cr | 317.36 Cr | 876.3220 Cr | 174.08 Cr | 118.52 Cr | 121.12 Cr | 660.26 Cr | 24.20 Cr | 10.32 Cr | 0.27 Cr | 172.4590 Cr |
2021-03-31 | 6.47 Cr | 996.62 Cr | 161.96 Cr | 834.6490 Cr | 54.13 Cr | 47.66 Cr | 23.05 Cr | 678.64 Cr | 11.53 Cr | 10.03 Cr | 5.62 Cr | 81.7490 Cr |
Annual Financials Cash Flow Statement
Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-31 | -31.3010 Cr | -43.3530 Cr | 82.2580 Cr | -102.7470 Cr | 7.6570 Cr | 34.8620 Cr | -71.4460 Cr | 6.2220 Cr | 112.7630 Cr | -12.9610 Cr | -84.0090 Cr |
2024-03-31 | 19.5960 Cr | 38.0730 Cr | -150.6930 Cr | -27.5110 Cr | 14.9360 Cr | 27.1800 Cr | -47.1070 Cr | 84.0770 Cr | 89.7390 Cr | -12.9610 Cr | -47.7580 Cr |
2023-03-31 | 67.7730 Cr | -61.0590 Cr | -50.0240 Cr | 49.2900 Cr | -43.3100 Cr | 12.2440 Cr | -18.4830 Cr | 102.0440 Cr | -24.3220 Cr | -10.8010 Cr | -64.2840 Cr |
2022-03-31 | 18.9170 Cr | -60.2820 Cr | 90.4590 Cr | -56.4770 Cr | 49.0950 Cr | 55.5760 Cr | -75.3940 Cr | 79.1460 Cr | 100.3160 Cr | -10.8010 Cr | -98.0720 Cr |
2021-03-31 | 84.3490 Cr | -56.9700 Cr | -29.3570 Cr | 57.7890 Cr | -1.9780 Cr | 6.4850 Cr | -26.5600 Cr | 55.0550 Cr | -20.1830 Cr | -5.4000 Cr | -5.2930 Cr |
Quarterly Financial Income Report
Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
---|---|---|---|---|---|---|---|---|---|
2025-06-30 | 296.43 Cr | 178.86 Cr | 117.56 Cr | 0.3966 | 25.02 Cr | 8.92 Cr | 0.71 | 48.55 Cr | 0.0301 |
2025-03-31 | 264.89 Cr | 226.61 Cr | 38.29 Cr | 0.1445 | 4.61 Cr | -11.02 Cr | -1.03 | 26.16 Cr | -0.0416 |
2024-12-31 | 275.63 Cr | 153.22 Cr | 122.42 Cr | 0.4441 | 17.59 Cr | -1.81 Cr | -0.17 | 39.33 Cr | -0.0066 |
2024-09-30 | 267.54 Cr | 218.09 Cr | 49.45 Cr | 0.1848 | 15.81 Cr | 3.39 Cr | 0.32 | 39.81 Cr | 0.0127 |
2024-06-30 | 278.89 Cr | 223.26 Cr | 55.63 Cr | 0.1995 | 28.84 Cr | 16.60 Cr | 1.37 | 45.21 Cr | 0.0595 |
Quarterly Financials Balance Sheet
Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
---|---|---|---|---|---|---|---|---|---|
2025-03-31 | 34.86 Cr | 94.63 Cr | 129.49 Cr | 175.21 Cr | 319.21 Cr | 657.96 Cr | 896.37 Cr | 1,703.65 Cr | 708.33 Cr |
2024-12-31 | 0.00 Cr | 0.00 Cr | 148.59 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,012.08 Cr |
2024-09-30 | 36.78 Cr | 111.81 Cr | 148.59 Cr | 171.36 Cr | 276.00 Cr | 677.90 Cr | 904.37 Cr | 1,716.61 Cr | 704.53 Cr |
2024-06-30 | -161.81 Cr | 323.62 Cr | 161.81 Cr | 0.00 Cr | 0.00 Cr | 161.81 Cr | 0.00 Cr | 0.00 Cr | -1,007.79 Cr |
2024-03-31 | 27.22 Cr | 80.64 Cr | 107.86 Cr | 147.12 Cr | 235.20 Cr | 552.25 Cr | 911.28 Cr | 1,607.53 Cr | 599.74 Cr |
Quarterly Financials Cash Flow Statement
Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|
2024-12-31 | -1.81 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-09-30 | 3.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-06-30 | 16.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2024-03-31 | 16.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
2023-12-31 | 19.07 Cr | 24.81 Cr | 0.00 Cr | 0.00 Cr | 24.81 Cr | 34.89 Cr | 10.08 Cr | 0.00 Cr | 24.81 Cr |
Splits History
Date | Label | Split Ratio |
---|---|---|
2022-12-22 | December 22, 22 | 6:5 |
Similar Stocks: Medical - Care Facilities
Company Name | Symbol | Price | Market Cap | Volume |
---|---|---|---|---|
Max Healthcare Institute Limited | MAXHEALTH | ₹1,112.00 | ₹1,081,082,936,120.00 | ₹48,050,369.00 |
Apollo Hospitals Enterprise Limited | APOLLOHOSP | ₹7,444.00 | ₹1,070,334,512,728.00 | ₹388,212.00 |
Fortis Healthcare Limited | FORTIS | ₹970.75 | ₹732,875,622,171.00 | ₹4,070,794.00 |
Narayana Hrudayalaya Limited | NH | ₹1,772.80 | ₹360,167,779,462.00 | ₹401,169.00 |
Global Health Limited | MEDANTA | ₹1,314.50 | ₹353,218,084,346.00 | ₹167,089.00 |
Aster DM Healthcare Limited | ASTERDM | ₹623.35 | ₹322,158,163,691.00 | ₹688,758.00 |
Krishna Institute of Medical Sciences Limited | KIMS | ₹701.00 | ₹280,497,393,435.00 | ₹473,563.00 |
Rainbow Children's Medicare Limited | RAINBOW | ₹1,340.50 | ₹136,130,032,402.00 | ₹116,015.00 |
Jupiter Life Line Hospitals Limited | JLHL | ₹1,493.40 | ₹97,916,297,255.00 | ₹29,309.00 |
HealthCare Global Enterprises Limited | HCG | ₹629.45 | ₹87,764,406,112.00 | ₹878,066.00 |
Yatharth Hospital & Trauma Care Services Limited | YATHARTH | ₹750.00 | ₹72,265,767,750.00 | ₹624,272.00 |
Indraprastha Medical Corporation Limited | INDRAMEDCO | ₹442.05 | ₹40,524,049,650.00 | ₹157,222.00 |
Kovai Medical Center and Hospital Limited | KOVAI | ₹2,581.00 | ₹35,290,787,300.00 | ₹5,780.00 |
Artemis Medicare Services Limited | ARTEMISMED | ₹231.06 | ₹32,101,143,849.00 | ₹68,310.00 |
Shalby Limited | SHALBY | ₹249.35 | ₹26,746,965,359.00 | ₹418,363.00 |
Key Executives
Gender: Not Specified
Year Born:
Gender: male
Year Born: 1980
Gender: male
Year Born:
Gender: male
Year Born:
Gender: Not Specified
Year Born: 1963
Gender: male
Year Born: 1978
Gender: male
Year Born:
Gender: Not Specified
Year Born:
FAQs about Shalby Limited
The CEO is Daniel Hayes.
The current price is ₹249.35.
The range is ₹177.25-282.5.
The market capitalization is ₹2,674.70 crores.
The P/E ratio is -6,094.71.
The company operates in the Healthcare sector.
Overview of Shalby Limited (ISIN: INE597J01018) is a leading Medical - Care Facilities in India. With a market capitalization of ₹2,674.70 crores and an average daily volume of 759,843 shares, it operates in the Medical - Care Facilities. The company last declared a dividend of ₹1.2.